Biosimilar Expansion: How Expiring Patents are Opening New Doors...

hat ein neuen Blog hinzugefügt Health

2026-01-13 15:23:07 -

The year 2026 marks a pivotal turning point for the biopharmaceutical sector as artificial intelligence (AI) moves from a experimental tool to the backbone of drug discovery. Traditional methods of antibody generation, which once took years of trial and error, are being replaced by generative models that predict binding affinities with surgical precision. This shift has not only accelerated the...

0 Kommentare 0 Geteilt 16 Ansichten 0 Bewertungen